v3.26.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 7,941,751 $ 8,235,469
Marketable securities 4,982,230 12,628,970
Prepaid expenses and other current assets 1,695,341 1,267,005
Deferred offering costs 493,596 320,581
Grant receivable 0 426,993
Total current assets 15,112,918 22,879,018
Total assets 15,112,918 22,879,018
Current liabilities:    
Accounts payable 2,272,497 1,454,118
Accrued expenses and other current liabilities 2,224,706 3,201,999
Total liabilities 4,497,203 4,656,117
Commitments and Contingencies  
Stockholders’ Equity:    
Common stock, $0.001 par value: 1,000,000,000 shares authorized at March 31, 2026 and December 31, 2025: 9,258,719 and 9,252,719 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 9,258 9,252
Additional paid-in capital 116,268,674 115,905,684
Accumulated other comprehensive (loss) income (208) 5,816
Accumulated deficit (105,662,009) (97,697,851)
Total stockholders' equity 10,615,715 18,222,901
Total liabilities and stockholders' equity 15,112,918 22,879,018
Series A Preferred Stock [Member]    
Stockholders’ Equity:    
Series A preferred stock $0.001 par value: 30,000,000 authorized at March 31, 2026 and December 31, 2025, 0 shares issued and outstanding at March 31, 2026 and December 31, 2025 $ 0 $ 0